Mark de Somer

Aegera Therapeutics is a clinical stage biotechnology company focused on developing targeted therapeutics to address major unmet medical needs. Aegera has three programs in clinical development, two for oncology and one for neuropathic pain. Aegera is also dedicated to identifying novel development candidates based upon its core technologies and internal expertise and experience in rapidly moving lead candidates through preclinical development and into clinical trials.

Oryn Therapeutics LLC develops and commercializes therapeutics. The private company is based in Vacaville.

AdhereTech LLC provides prescription drug packaging solutions. The firm develops smart pill bottle that enables to know when pills and liquid medication is missed by patients. The company was founded by Josh Stein and is headquartered in New York, NY.

Spring Discovery, Inc. provides machine learning-based drug discovery platform. It built a machine learning platform to accelerate experimentation for discovering therapies for aging and its related diseases. The company was founded by Ben Kamens and is headquartered in Paolo Alto, California.

Trialspark, Inc(Trialspark) is a Private Equity firm founded in 2013 by Benjamine Liu, Kit Dobyns, and Linhao Zhang. The firm is headquartered in New York, US.

LikeMinds, Inc. intends to make brain imaging part of the standard suite of healthcare diagnostic tests and technologies. The company was founded in 2018 and is headquartered in Boston, MA.

Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London.

eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.

Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.

Skura Corp. develops and delivers sales enablement solutions. It offers SKURA SFX sales enablement suite that delivers SFX Viewer, a digital detailing software solution; SFX Webflow, a personal and non-personal cloud presentation delivery solution; and channel mix optimizer, a predictive analytics solution. The firm provides SFX Grid, a Web-based centralized administration application that enables sales content, user, file and mobile application management for the Skura connectivity platform; SFX AnalytiX, an analytics solution that delivers real-time insight and reporting; and SFX connections, which allows for the managing and nurturing of sales representatives interactions with customers, clients and sales prospects. The company was founded by Chris Skura in 1996 and is headquartered in Oakville, Canada.

Citibank Canada provides banking solutions. The firm provides financial solutions in corporate and investment banking, credit cards, consumer finance, investment, leasing, private, and retail banking services. It offers services to corporations, financial institutions, government agencies, and individuals. The bank operates in Canada through the Citibank, Citi Cards Canada, CitiFinancial, Citi Global Markets, Primerica, and Diners Club franchises. Citibank Canada was founded in 1954 and is headquartered in Toronto, Canada.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers Securities Ltd. is an Australian company that provides accounting services. The company is based in Southbank, Australia.

Pacific Vector Holdings, Inc. operates as a action sports retail and consumer brands company. The company was founded on September 1, 2005 and is headquartered in Carlsbad, CA.

Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON.

The Knights is an orchestral collective that is flexible in size and repertory. The private company is based in Brooklyn. The American company is on a quest to expand the boundaries of classical music and imagine new possibilities for the art form as they explore a wide universe of music. The company offers performances, partnerships, and collaborations in education. The Knights also have a patron program and an innovation fund. The company's support inspires them, sustains them, and helps make possible the incredible adventures ahead.

GLYCODesign, Inc. develops pharmaceutical products. The company engages in the discovery and development of novel therapeutics for life-threatening diseases such as cancer, infectious diseases, inflammation, and cardiovascular diseases. GLYCODesign focuses on inhibiting the enzymes that produce the abnormal carbohydrates. The company was founded by Jeremy Carver in 1993 and is headquartered in Toronto, Canada.

PlantForm Corp. engages in a biopharmaceutical company. It focuses on the development and production of ntibody and protein drugs using manufacturing platform. The firm’s vivoXPRESS technology uses genetically modified tobacco plants to produce biopharmaceuticals in fully contained greenhouse environments. The company was founded by J. Christopher Hall, Mark Goldberg, Don Stewart, and Ronald G. Hosking in 2008 and is headquartered in Toronto, Canada.

Part of DMK Pharmaceuticals Corp., Vaxis Therapeutics Corp manufactures and researches pharmaceutical products. The company is based in Kingston, Canada. Vaxis Therapeutics was acquired by Cellegy Pharmaceuticals, Inc. on November 29, 2001 for $4 million.

Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada.